Inhibitex to Host Conference Call to Report Fourth Quarter and Year-End 2010 Financial Results on March 11, 2011
February 28 2011 - 9:00AM
Business Wire
Inhibitex, Inc. (NASDAQ: INHX) announced today that it will host
a conference call on Friday, March 11, 2011, at 9:00 a.m. EST to
review the Company’s fourth quarter and year-end December 31, 2010,
financial results and provide an update on recent corporate
developments. The Company will issue a press release regarding its
financial results on the same day, prior to the conference
call.
Webcast Information
To access the conference call, please dial (877) 407-9210
(domestic) or (201) 689-8049 (international). A replay of the call
will be available from 11:00 a.m. Eastern Time on March 11th until
April 12, 2011, at midnight. To access the replay, please dial
(877) 660-6853 (domestic) or (201) 612-7415 (international) and
reference the account # 286 and the conference id # 366809. A live
audio webcast of the call and the archived webcast will be
available in the News and Events section of the Inhibitex website
at http://www.inhibitex.com.
About Inhibitex
Inhibitex, Inc., headquartered in Alpharetta, Georgia, is a
biopharmaceutical company focused on developing products to prevent
and treat serious infectious diseases. The Company’s pipeline
includes FV-100, which is in Phase II clinical development for the
treatment of shingles, and INX-189, a nucleotide polymerase
inhibitor in Phase 1 clinical development for the treatment of
chronic hepatitis C infections. The Company also has additional HCV
nucleotide polymerase inhibitors in preclinical development and has
licensed the use of its proprietary MSCRAMM® protein platform to
Pfizer for the development of staphylococcal vaccines.
For additional information about the Company, please visit
www.inhibitex.com.
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jul 2023 to Jul 2024